Skillman, NJ, United States of America

Sterling Johnson

This inventor holds 1 USPTO granted patent. Top assignee: Escalon Ophthalmics, Inc.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sterling Johnson. Retrieved from https://idiyas.com/inventor/sterling-johnson-z8np5a9u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 319(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sterling Johnson

Introduction

Sterling Johnson is a notable inventor based in Skillman, NJ (US), recognized for his significant contributions to the field of ophthalmology. He holds a patent for a unique device designed for intraocular drug delivery, showcasing his commitment to advancing medical technology.

Latest Patents

Johnson's patent, titled "Tack for intraocular drug delivery and method for inserting and removing," presents a groundbreaking solution for sustained drug release within the eye. The device consists of a post, an anchoring region, and a head, designed to be positioned within the vitreous region of the eye. The post contains a drug to be administered, while the anchoring region is engineered to secure the tack within the sclera, retina, or choroid. This innovative design allows for effective drug delivery while ensuring that the head remains external to the eye, providing a practical solution for patients requiring ongoing treatment.

Career Highlights

Sterling Johnson is affiliated with Escalon Ophthalmics, Inc., where he continues to develop and refine his inventions. His work has contributed to advancements in ophthalmic procedures, enhancing the quality of care for patients with eye conditions.

Collaborations

Johnson collaborates with esteemed colleagues, including Alan L. Weiner and Kevin Sinnett, who share his vision for improving ocular health through innovative solutions.

Conclusion

Sterling Johnson's contributions to intraocular drug delivery represent a significant advancement in ophthalmic technology. His dedication to innovation continues to impact the field positively, improving patient outcomes and setting new standards in medical treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…